This result was consistent with a study on bladder cancer that showed that TP53INP2 could regulate the EMT through GSK-3β signaling, supporting the idea that it has autophagy-inducing and EMT regulatory functions in HLE cells. Here, TP53INP2 is linked to urinary bladder cancer.